Hilton Capital Management LLC Buys 268 Shares of Teleflex Incorporated (NYSE:TFX)

Hilton Capital Management LLC grew its stake in shares of Teleflex Incorporated (NYSE:TFX) by 4.6% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 6,086 shares of the medical technology company’s stock after buying an additional 268 shares during the quarter. Hilton Capital Management LLC’s holdings in Teleflex were worth $1,083,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of TFX. Vontobel Holding Ltd. raised its holdings in Teleflex by 21.9% in the 4th quarter. Vontobel Holding Ltd. now owns 1,393 shares of the medical technology company’s stock valued at $248,000 after buying an additional 250 shares during the last quarter. Simplify Asset Management Inc. bought a new stake in Teleflex during the 3rd quarter worth approximately $4,800,000. JPMorgan Chase & Co. grew its holdings in Teleflex by 14.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company’s stock worth $38,374,000 after acquiring an additional 19,466 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. grew its holdings in Teleflex by 5.2% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 108,231 shares of the medical technology company’s stock worth $19,263,000 after acquiring an additional 5,322 shares during the last quarter. Finally, Lecap Asset Management Ltd. bought a new stake in Teleflex during the 4th quarter worth approximately $729,000. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Stock Up 1.1 %

Shares of NYSE TFX opened at $137.79 on Friday. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The firm has a market cap of $6.39 billion, a PE ratio of 27.39, a P/E/G ratio of 1.73 and a beta of 1.21. The company’s fifty day simple moving average is $166.99 and its 200 day simple moving average is $197.99. Teleflex Incorporated has a 12-month low of $128.55 and a 12-month high of $249.90.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company had revenue of $795.40 million for the quarter, compared to analysts’ expectations of $813.24 million. As a group, sell-side analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Friday, March 7th will be given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.99%. The ex-dividend date is Friday, March 7th. Teleflex’s payout ratio is 95.77%.

Wall Street Analyst Weigh In

A number of research firms have weighed in on TFX. StockNews.com lowered shares of Teleflex from a “buy” rating to a “hold” rating in a report on Friday, February 28th. Wells Fargo & Company reduced their target price on shares of Teleflex from $214.00 to $146.00 and set an “equal weight” rating on the stock in a report on Friday, February 28th. Raymond James lowered shares of Teleflex from an “outperform” rating to a “market perform” rating in a report on Friday, February 28th. Bank of America lowered shares of Teleflex from a “neutral” rating to an “underperform” rating and reduced their target price for the stock from $235.00 to $140.00 in a report on Tuesday, March 4th. Finally, Royal Bank of Canada downgraded shares of Teleflex from an “outperform” rating to a “sector perform” rating and dropped their price target for the stock from $220.00 to $155.00 in a research report on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $182.63.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.